🔎 Trials Near Me

Početna › Rak (sve vrste) › Michigan

Kliničke studije za Rak (sve vrste) u državi Michigan

74 studija za Rak (sve vrste) traži sudionike na lokacijama u državi Michigan.

Gradovi u državi Michigan

Službeni tekst studije (engleski)

A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)

  • START Midwest ( Site 1103), Grand Rapids
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07209111

A Study of ASP3082 in Adults With Advanced Solid Tumors

  • Trinity Health Ann Arbor Hospital, Ypsilanti
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT05382559

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

  • START Midwest /ID# 279035, Grand Rapids
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07409246

REC-7735 in Participants With Solid Tumors

  • START Midwest, Grand Rapids
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07819136

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

  • University of Michigan, Ann Arbor
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT05874921

Registry Study for Radiation Therapy Outcomes

  • McLaren Proton Therapy Center, Flint
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 29. ruj 2026. · NCT01255748

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

  • Corewell Health ( Site 4001), Grand Rapids
U tijeku regrutacijaFaza 1/2
1 Month – 17 Years · Oba spola · Ažurirano 25. ruj 2026. · NCT07630974

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

  • University of Michigan, Ann Arbor
  • Start Midwest, Grand Rapids
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06150157

A Study of JNJ-87890387 for Advanced Solid Tumors

  • Start Midwest, Grand Rapids
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06178614

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

  • University of Michigan Health System, Ann Arbor
  • Barbara Ann Karmanos Cancer Center, Detroit
  • Henry Ford Cancer Institute-Henry Ford Hospital, Detroit
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT06901531

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  • Quetzal Site 22, Ann Arbor
U tijeku regrutacijaFaza 3
Od 18 do 71 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT07504458

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

  • Karmanos Cancer Center ( Site 0108), Detroit
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT07405164

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

  • Cancer And Hematology Centers Of Western Michigan - Grand Rapids /ID# 279955, Grand Rapids
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT07365241

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • START Midwest, Grand Rapids
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT06128551

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • Trinity Health Ann Arbor Hospital, Ann Arbor
  • Henry Ford Health Saint John Hospital, Detroit
  • Genesys Hurley Cancer Institute, Flint
  • i još 7
U tijeku regrutacijaFaza 2
Od 12 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT02693535

Support for Bereaved Cancer Caregivers

  • Michigan State University College of Nursing, East Lansing
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 18. ruj 2026. · NCT06662409

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

  • University Of Michigan Comprehensive Cancer Center, Ann Arbor
  • Karmanos Cancer Center Wayne State University, Detroit
U tijeku regrutacijaFaza 2/3
Sve dobne skupine · Oba spola · Ažurirano 18. ruj 2026. · NCT03435796

Connect for Cancer Prevention Study (Connect)

  • Henry Ford Health Systems, Detroit
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 30 do 70 godina · Oba spola · Ažurirano 17. ruj 2026. · NCT04609072

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

  • Corewell Health ( Site 3001), Grand Rapids
U tijeku regrutacijaFaza 1/2
1 Month – 17 Years · Oba spola · Ažurirano 17. ruj 2026. · NCT06941272

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

  • GSK Investigational Site, Detroit
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT07213609

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • University of Michigan, Ann Arbor
  • Henry Ford Health, Novi
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07002034

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

  • University of Michigan Health System - Ann Arbor /ID# 271536, Ann Arbor
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT06953960

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • University of Michigan, Ann Arbor
  • Henry Ford Cancer Institute, Detroit
  • START - Midwest Cancer Research Center, Grand Rapids
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT06253871

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

  • Henry Ford Hospital, Detroit
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT05386108

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • University of Michigan, Ann Arbor
  • The Cancer & Hematology Centers, Grand Rapids
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06119581

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

  • Cancer and Hematology Centers of Western Michigan, Grand Rapids
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT06252649

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

  • Henry Ford, Detriot
  • Karmanos Cancer Institute, Detroit
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT06163534

Lurbinectedin in FET-Fused Tumors

  • University of Michigan, Ann Arbor
U tijeku regrutacijaFaza 1/2
Od 10 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT05918640

Prostate Active Surveillance Study

  • University of Michigan, Ann Arbor
U tijeku regrutacijaOpažajna studija
Od 21 godina i više · Muškarci · Ažurirano 2. ruj 2026. · NCT00756665

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

  • START Midwest, Grand Rapids
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 26. kol 2026. · NCT07321106

Project: Every Child for Younger Patients With Cancer

  • C S Mott Children's Hospital, Ann Arbor
  • Bronson Battle Creek, Battle Creek
  • Children's Hospital of Michigan, Detroit
  • i još 14
U tijeku regrutacijaOpažajna studija
Do 25 godina · Oba spola · Ažurirano 25. kol 2026. · NCT02402244

Abatacept in Immune Checkpoint Inhibitor Myocarditis

  • University of Michigan, Ann Arbor
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 20. kol 2026. · NCT05335928

Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

  • Site 04, Grand Rapids
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 19. kol 2026. · NCT07276373

A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

  • START Midwest, Grand Rapids
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 12. kol 2026. · NCT06759649

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • Karmanos Cancer Institute, Detroit
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 11. kol 2026. · NCT05592626

A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

  • START Midwest, Grand Rapids
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 10. kol 2026. · NCT06880549

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

  • C.S. Mott Children's Hospital, Ann Arbor
U tijeku regrutacijaFaza 2
Od 1 do 39 godina · Oba spola · Ažurirano 7. kol 2026. · NCT05999994

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • MyMichigan Medical Center Gratiot, Alma
  • MyMichigan Medical Center Alpena, Alpena
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • i još 49
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 7. kol 2026. · NCT06580314

A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer

  • BAMF Health Inc., Grand Rapids
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 6. kol 2026. · NCT07258836

Ask Questions About Clinical Trials

  • Karmanos Cancer Institute at McLaren Bay Region, Bay City
  • Karmanos Cancer Institute at McLaren Clarkston, Clarkston
  • Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
  • i još 5
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 6. kol 2026. · NCT07343297

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.